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How to Optimize Left
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Coronary Intervention*Seung-Jung Park, MD, PHD, Jung-Min Ahn, MD,
Young-Hak Kim, MD, PHD
Seoul, South Korea
As a result of the demonstrated survival beneﬁt of coronary
artery bypass surgery over medical treatment, and the un-
favorable initial results of coronary balloon angioplasty,
coronary artery bypass grafting (CABG) has been the
standard care for signiﬁcant left main coronary artery
(LMCA) stenosis (1,2).See page 717Despite unfavorable outcomes in the early era of LMCA
percutaneous coronary intervention (PCI), intervention-
alists have continued attempting percutaneous treatment
for LMCA stenosis (3). Technical advances in PCI and
stent technology, particularly with the widespread avail-
ability of drug-eluting stents (DES), have led physicians to
re-evaluate the role of PCI as a viable alternative treatment
for unprotected LMCA disease. As a result, during the
last decade, the prevalence of LMCA stenting has
signiﬁcantly increased worldwide. In addition, several recent
large registries and randomized controlled trials such as the
MAIN-COMPARE (Revascularization for Unprotected
Left Main Coronary Artery Stenosis: Comparison of Percu-
taneous Coronary Angioplasty Versus Surgical Revasculari-
zation) registry, SYNTAX (SYNergy Between PCI With
TAXUS and Cardiac Surgery), and PRECOMBAT (PRE-
mier of Randomized COMparison of Bypass Surgery Versus
AngioplasTy Using Sirolimus-Eluting Stent in Patients
With Left Main Coronary Artery Disease) randomized trials
have demonstrated that LMCA stenting yields comparable
mortality and morbidity rates to CABG (4–6). Currently, the
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this paper to disclose.has been updated toClass IIa, Level of Evidence: B depending
on anatomic complexity of coronary artery disease (7). It is
obvious that PCI has become more generally applicable to
patients in elective situations beyond the very limited use in
patients who are poor candidates for CABG.
In this issue of JACC: Cardiovascular Interventions,
Almudarra et al. (8) used national data from the British
Cardiovascular Intervention Society to report the clinical
outcomes of 5,065 patients undergoing PCI of an unpro-
tected left main stenosis in the United Kingdom from
2005 to 2010. Patients were categorized into 3 clinical
syndromes: ST-segment elevation myocardial infarction
(STEMI), non–ST-segment acute coronary syndrome
(NSTEACS), or chronic stable angina (CSA). The in-
vestigators evaluated the outcomes as a function of clinical
presentation. STEMI or NSTEACS patients, compared
with CSA patients, had signiﬁcantly higher mortality at 30
days (1.4% vs. 8.9% vs. 28.3%, respectively) and at 1 year
(7.0% vs. 19.5% vs. 37.6%, respectively). Forty percent of the
patients presented with cardiogenic shock. Mortality at 1
year after STEMI with cardiogenic shock was signiﬁcantly
higher than in STEMI without shock (65% vs. 30%). This
study is of value as the ﬁrst whole-country outcomes study
of LMCA PCI and demonstrates that LMCA PCI is
feasible in a variety of clinical presentations. Particularly,
CSA patients composed 37.5% of the study population
and showed very favorable clinical outcomes. However,
several modiﬁable procedural factors need to be addressed to
achieve better outcomes of LMCA stenting.
First, intravascular ultrasound (IVUS) was used in only
35.9% of CSA patients, which is lower compared with that
reported in other studies (4,6). IVUS provides accurate in-
formation about stent sizing and helps to detect suboptimal
stent deployment or stent-related complications, thereby
making LMCA PCI safer and more effective. Previously,
the MAIN-COMPARE registry, and more recently, the
de la Torre Hernandez et al. (10) study, demonstrated that
IVUS-guided LMCA stenting is associated with less mor-
tality (9,10). Second, for the distal left main disease, the
PCI strategy may affect the prognosis. In general, the single-
stent technique clearly shows more favorable long-term
clinical outcomes compared with the 2-stent technique, even
in true bifurcation stenosis (11). Selection of a single- or
2-stent technique should be based on disease involvement
and the territory supplied by the left circumﬂex ostium.
IVUS provides accurate information for both main and side
branch disease status and was helpful in the decision of
treatment strategy. Therefore, more frequent selection of
the single-stent technique guided by the IVUS may reduce
the adverse events over time. Third, a pressure wire for
fractional ﬂow measurement (FFR) was used in only 12%
of CSA patients. Traditionally, angiographic diameter ste-
nosis of 50% has been considered a cutoff for signiﬁcant
LMCA stenosis (4–6). However, the conventional coronary
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732angiogram has limitations in assessing functional severity
of LMCA stenosis. In addition, noninvasive functional
testing, such as a myocardial perfusion imaging, is often
noncontributory in the diagnosis of patients with a LMCA
stenosis. Therefore, direct measurement of FFR may be
helpful in deciding whether to perform revascularization of
LMCA stenosis, particularly ostial or shaft stenosis. Using
this measure, unnecessary LMCA PCI could be avoided.
Several studies already demonstrated that FFR-guided de-
cision making for the treatment of LMCA is associated with
favorable prognosis and the intermediate LMCA lesion
with FFR ¼ 0.75 to 0.80 could be safely deferred (12). In
addition, for LMCA stenosis, if FFR measurement is not
feasible, the IVUS minimal lumen area (¼ 4.8 mm2) could
be used as a deﬁnition of signiﬁcant functional stenosis (13).
Fourth, the DES implantation is of paramount importance
in PCI for unprotected LMCA stenosis. In this cohort,
they still used bare-metal stents in a substantial number of
these patients. Although the LMCA itself appeared to be
relatively resistant to restenosis because of its large caliber,
PCI with bare-metal stents for distal left main bifurcation
lesions or for the associated extra-LMCA disease has shown
a high event rate. In fact, meta-analysis of observational
studies and randomized controlled trials involving 10,342
patients with unprotected LMCA stenosis demonstrated
signiﬁcantly lower crude mortality and adverse event rates
in DES-implanted patients than in those with bare-metal
stents (14). In addition, the wide use of second-generation
DES, which have been safer and more effective than ﬁrst-
generation DES, could further reduce the event rate of
LMCA PCI in recent years (15).
Currently, another randomized trial comparing PCI with
everolimus-eluting stents to CABG, using endpoints of
death, myocardial infarction, and stroke (EXCEL [EXCEL
Clinical Trial; Evaluation of XIENCE PRIME Ever-
olimus Eluting Stent System (EECSS) or XIENCE V
EECSS or XIENCE Xpedition EECSS or XIENCE
PRO EECSS Versus Coronary Artery Bypass Surgery for
Effectiveness of Left Main Revascularization]) is in pro-
cess. This trial adopted recent stent technology, a distal
left main PCI strategy, and adjuvant techniques of IVUS
and FFR, and thereby may further clarify the current status
and role of PCI compared with CABG for signiﬁcant
LMCA stenosis.
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